{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:38:54Z","timestamp":1790836734713,"version":"4.1.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":35,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:p>Widespread and long\u2010term use of oral nucleos(t)ide analogs (NAs) to treat chronic hepatitis B (CHB) brings about safety data in a real\u2010life setting. We aimed to determine the risks of renal and bone side effects in patients receiving or who have received NAs as CHB treatment. A territory\u2010wide cohort study using the database from Hospital Authority, the major provider of medical services in Hong Kong, was conducted. We identified CHB patients by International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes, diagnosed between 2000 and 2012. The primary events were renal (incident renal failure and renal replacement therapy [RRT]) and bone events (incident hip, vertebral, and all fractures). A 3\u2010year landmark analysis was used to evaluate the relative risk of primary outcome in patients with or without NA treatment. A total of 53,500 CHB patients (46,454 untreated and 7,046 treated), who were event free for 3 years, were included in the analysis. At a median follow\u2010up of 4.9 years, chronic renal failure, RRT, all fractures, hip fractures, and vertebral fractures occurred in 0.6%, 0.2%, 0.7%, 0.1%, and 0.1% of untreated subjects and 1.4%, 0.7%, 1.3%, 0.2%, and 0.2% of treated subjects. After propensity score weighting, NA therapy did not increase the risk of any of the events (hazard ratios [HRs] ranged from 0.79 to 1.31; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.225\u20100.887). Exposure to nucleotide analogues, compared with nucleoside analogs, increased the risk of hip fracture (HR\u2009=\u20095.69; 95% confidence interval: 1.98\u201016.39; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2009=\u20090.001), but not other events (HR\u2009=\u20090.58\u20101.44; <jats:italic toggle=\"yes\">P =<\/jats:italic> 0.202\u20100.823). <jats:italic toggle=\"yes\">Conclusions<\/jats:italic>: NA treatment does not increase the risk of renal and bone events in general. Nucleotide analogs may increase the risk of hip fracture, but the overall event rate is low. (H<jats:sc>epatology<\/jats:sc> 2015;62:684\u2013693)<\/jats:p>","DOI":"10.1002\/hep.27894","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T08:27:27Z","timestamp":1431592047000},"page":"684-693","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":88,"title":["Long\u2010term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects"],"prefix":"10.1097","volume":"62","author":[{"given":"Grace Lai\u2010Hung","family":"Wong","sequence":"first","affiliation":[{"name":"Institute of Digestive Disease, The Chinese University of Hong Kong,Hong Kong"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee\u2010Kit","family":"Tse","sequence":"additional","affiliation":[{"name":"Institute of Digestive Disease, The Chinese University of Hong Kong,Hong Kong"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Wai\u2010Sun","family":"Wong","sequence":"additional","affiliation":[{"name":"Institute of Digestive Disease, The Chinese University of Hong Kong,Hong Kong"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry Cheuk\u2010Fung","family":"Yip","sequence":"additional","affiliation":[{"name":"Department of Statistics,The Chinese University of Hong Kong,Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin Kam\u2010Fai","family":"Tsoi","sequence":"additional","affiliation":[{"name":"Big Data Decision Analytics Research Center, The Chinese University of Hong Kong,Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Lik\u2010Yuen","family":"Chan","sequence":"additional","affiliation":[{"name":"Institute of Digestive Disease, The Chinese University of Hong Kong,Hong Kong"},{"name":"Department of Medicine and Therapeutics,The Chinese University of Hong Kong,Hong Kong"},{"name":"State Key Laboratory of Digestive Disease,The Chinese University of Hong Kong,Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2015,7,28]]},"reference":[{"key":"hep27894-bib-0001-20241017","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"hep27894-bib-0002-20241017","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrgastro.2011.33","article-title":"Hepatitis B therapy","volume":"8","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"hep27894-bib-0003-20241017","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/17474124.2014.909724","article-title":"Current developments in nucleoside\/nucleotide analogues for hepatitis B","volume":"8","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"hep27894-bib-0004-20241017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"hep27894-bib-0005-20241017","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian\u2010Pacific consensus statement on the management of chronic hepatitis B: a 2012 update","volume":"6","year":"2012","journal-title":"Hepatol Int"},{"key":"hep27894-bib-0006-20241017","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","year":"2009","journal-title":"Hepatology"},{"key":"hep27894-bib-0007-20241017","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long\u2010term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","year":"2003","journal-title":"Gastroenterology"},{"key":"hep27894-bib-0008-20241017","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa042957","article-title":"Long\u2010term therapy with adefovir dipivoxil for HBeAg\u2010negative chronic hepatitis B","volume":"352","year":"2005","journal-title":"N Engl J Med"},{"key":"hep27894-bib-0009-20241017","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long\u2010term therapy with adefovir dipivoxil for HBeAg\u2010negative chronic hepatitis B for up to 5 years","volume":"131","year":"2006","journal-title":"Gastroenterology"},{"key":"hep27894-bib-0010-20241017","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5\u2010year open\u2010label follow\u2010up study","volume":"381","year":"2013","journal-title":"Lancet"},{"key":"hep27894-bib-0011-20241017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1053\/jhep.2001.20533","article-title":"Hepatic osteodystrophy","volume":"33","year":"2001","journal-title":"Hepatology"},{"key":"hep27894-bib-0012-20241017","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.22790","article-title":"The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen\u2010positive and hepatitis B e antigen\u2010negative hepatitis B virus strains","volume":"49","year":"2009","journal-title":"Hepatology"},{"key":"hep27894-bib-0013-20241017","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00774-012-0384-y","article-title":"Hypophosphatemic osteomalacia induced by low\u2010dose adefovir therapy: focus on manifestations in the skeletal system and literature review","volume":"31","year":"2013","journal-title":"J Bone Miner Metab"},{"key":"hep27894-bib-0014-20241017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10620-014-3336-7","article-title":"Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in asians with chronic hepatitis B","volume":"60","year":"2015","journal-title":"Dig Dis Sci"},{"key":"hep27894-bib-0015-20241017","first-page":"609","article-title":"Structured data entry of clinical information for documentation and data collection","volume":"84","year":"2001","journal-title":"Stud Health Technol Inform"},{"key":"hep27894-bib-0017-20241017","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis","volume":"58","year":"2013","journal-title":"Hepatology"},{"key":"hep27894-bib-0018-20241017","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s00198-010-1490-0","article-title":"Bone mineral density enhances use of clinical risk factors in predicting ten\u2010year risk of osteoporotic fractures in Chinese men: the Hong Kong Osteoporosis Study","volume":"22","year":"2011","journal-title":"Osteoporos Int"},{"key":"hep27894-bib-0019-20241017","first-page":"28","article-title":"Hong Kong Renal Registry Report 2012. Hong Kong","volume":"15","year":"2013","journal-title":"J Nephrol"},{"key":"hep27894-bib-0020-20241017","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","year":"2010","journal-title":"BMJ"},{"key":"hep27894-bib-0021-20241017","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","article-title":"Analysis of survival by tumor response","volume":"1","year":"1983","journal-title":"J Clin Oncol"},{"key":"hep27894-bib-0022-20241017","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","article-title":"Landmark analysis at the 25\u2010year landmark point","volume":"4","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"hep27894-bib-0023-20241017","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s10620-014-3486-7","article-title":"Seven\u2010year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection","volume":"60","year":"2015","journal-title":"Dig Dis Sci"},{"key":"hep27894-bib-0024-20241017","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/0003-4819-137-8-200210150-00015","article-title":"Rare outcomes, common treatments: analytic strategies using propensity scores","volume":"137","year":"2002","journal-title":"Ann Intern Med"},{"key":"hep27894-bib-0025-20241017","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1037\/1082-989X.9.4.403","article-title":"Propensity score estimation with boosted regression for evaluating causal effects in observational studies","volume":"9","year":"2004","journal-title":"Psychol Methods"},{"key":"hep27894-bib-0026-20241017","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/sim.5753","article-title":"A tutorial on propensity score estimation for multiple treatments using generalized boosted models","volume":"32","year":"2013","journal-title":"Stat Med"},{"key":"hep27894-bib-0027-20241017","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1214\/aos\/1013203450","article-title":"Greedy function approximation: a gradient boosting machine","volume":"29","year":"2001","journal-title":"Ann Stat"},{"key":"hep27894-bib-0028-20241017","first-page":"465","article-title":"Discussion of \u2018least angle regression\u2019 by Efron et al","volume":"32","year":"2004","journal-title":"Ann Stat"},{"key":"hep27894-bib-0029-20241017","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity\u2010score matched samples","volume":"28","year":"2009","journal-title":"Stat Med"},{"key":"hep27894-bib-0030-20241017","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jamcollsurg.2009.10.021","article-title":"Missing data in the American College of Surgeons National Surgical Quality Improvement Program are not missing at random: implications and potential impact on quality assessments","volume":"210","year":"2010","journal-title":"J Am Coll Surg"},{"key":"hep27894-bib-0031-20241017","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJMsr1203730","article-title":"The prevention and treatment of missing data in clinical trials","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"hep27894-bib-0032-20241017","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model","volume":"28","year":"2009","journal-title":"Stat Med"},{"key":"hep27894-bib-0033-20241017","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time\u2010to\u2010event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","year":"2014","journal-title":"Stat Med"},{"key":"hep27894-bib-0034-20241017","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/sim.4780100410","article-title":"Multiple imputation in health\u2010care databases: an overview and some applications","volume":"10","year":"1991","journal-title":"Stat Med"},{"key":"hep27894-bib-0035-20241017","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/14740338.2012.672972","article-title":"Safety of long\u2010term nucleos(t)ide treatment in chronic hepatitis B","volume":"11","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"hep27894-bib-0036-20241017","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1517\/14740338.2012.653340","article-title":"Long\u2010term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV\u2010901","volume":"11","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"hep27894-bib-0037-20241017","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1128\/AAC.00350-08","article-title":"Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"hep27894-bib-0039-20241017","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM199105233242103","article-title":"Membranous nephropathy related to hepatitis B virus in adults","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"hep27894-bib-0040-20241017","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cgh.2006.10.015","article-title":"Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease","volume":"5","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep27894-bib-0041-20241017","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.gastro.2005.03.089","article-title":"Hepatitis C virus\u2010replicating hepatocytes induce fibrogenic activation of hepatic stellate cells","volume":"129","year":"2005","journal-title":"Gastroenterology"},{"key":"hep27894-bib-0042-20241017","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cgh.2014.09.050","article-title":"Adverse effects of vitamin D deficiency on outcomes of patients with chronic hepatitis B","volume":"13","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep27894-bib-0043-20241017","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jhep.2014.04.001","article-title":"Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"hep27894-bib-0044-20241017","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jgh.12499","article-title":"Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment","volume":"29","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"hep27894-bib-0045-20241017","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1002\/sim.1271","article-title":"Dealing with competing risks: testing covariates and calculating sample size","volume":"21","year":"2002","journal-title":"Stat Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27894","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201509000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T01:02:20Z","timestamp":1729213340000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201509000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,28]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27894","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,28]]},"assertion":[{"value":"2015-02-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-04-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}